Health and Fitness Health and Fitness
Thu, December 9, 2010
[ Thu, Dec 09th 2010 ] - Market Wire
Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2011
[ Thu, Dec 09th 2010 ] - Market Wire
Pacific Biosciences and Harvard Scientists Decode Genome of Haitian Cholera Pathogen
[ Thu, Dec 09th 2010 ] - Market Wire
Aetna Statement on Passing of Former Chairman, CEO and Board Member James T. Lynn
[ Thu, Dec 09th 2010 ] - Market Wire
Alnylam Elects Marsha Fanucci to its Board of Directors
[ Thu, Dec 09th 2010 ] - Market Wire
Hi-Tech Pharmacal Reports Sales of $44.9 Million .. the Second Fiscal Quarter Ended October 31, 2010
[ Thu, Dec 09th 2010 ] - Market Wire
CENTRIC HEALTH TO ACQUIRE SURGICAL SPACES INC. TO .. EXPAND ITS NATIONAL NETWORK OF HEALTHCARE CENTRES
[ Thu, Dec 09th 2010 ] - Market Wire
PROTOX ANNOUNCES PUBLICATION OF PRX302 CLINICAL D .. BENIGN PROSTATIC HYPERPLASIA IN EUROPEAN UROLOGY
[ Thu, Dec 09th 2010 ] - Market Wire
Beach Cities Launch Initiative to Become First Healthways | Blue Zones Vitality City
[ Thu, Dec 09th 2010 ] - Market Wire
Gallup and Healthways Release November 2010 U.S. Well-Being Report
Wed, December 8, 2010
[ Wed, Dec 08th 2010 ] - Market Wire
XenoPort Announces Pricing of Public Offering of Common Stock
[ Wed, Dec 08th 2010 ] - Market Wire
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
[ Wed, Dec 08th 2010 ] - Market Wire
Medisafe 1 Technologies Meets With Israel's Minis .. r of Health to Demonstrate Syringe Locking Device
[ Wed, Dec 08th 2010 ] - Market Wire
Geron Corporation Announces Full Exercise of Over-Allotment Option
[ Wed, Dec 08th 2010 ] - Market Wire
Faruqi & Faruqi, LLP Is Investigating Genoptix, Inc. On Behalf of Its Shareholders - GXDX
[ Wed, Dec 08th 2010 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation Rela .. saction of Caraco Pharmaceutical Laboratories Ltd
[ Wed, Dec 08th 2010 ] - Market Wire
XenoPort Announces Proposed Public Offering of Common Stock
[ Wed, Dec 08th 2010 ] - Market Wire
Alnylam to Webcast Presentation at 2010 Deutsche Bank BioFEST
[ Wed, Dec 08th 2010 ] - Market Wire
El programa Give for Real de Mannatech permite qu .. na importante donacin a la Fundacin Vamos M©xico
[ Wed, Dec 08th 2010 ] - Market Wire
Alkermes Announces Results from Phase 2 Study of ALKS 33 in Alcohol Dependence
[ Wed, Dec 08th 2010 ] - Market Wire
St. Jude Medical Advances Integration of Electrop .. Equipment with Launch of Several New Technologies
[ Wed, Dec 08th 2010 ] - Market Wire
ImmunoCellular Therapeuticsa? Chief Executive Off .. resent at Prestigious Cancer Stem Cell Conference
[ Wed, Dec 08th 2010 ] - Market Wire
CHINA HEALTH LABS &; DIAGNOSTICS LTD. ANNOUNCES R .. CH &; DEVELOPMENT AGREEMENT WITH CHINESE MILITARY
[ Wed, Dec 08th 2010 ] - Market Wire
CIGNA Announces Completion of Tender Offer for Any and All of Its 8.50% Senior Notes Due 2019
[ Wed, Dec 08th 2010 ] - Market Wire
InSite Vision to Host Investor Conference Call Introducing New CEO Timothy Ruane
[ Wed, Dec 08th 2010 ] - Market Wire
CytRx Announces Compliance with NASDAQ's Minimum Bid Requirement
[ Wed, Dec 08th 2010 ] - Market Wire
Clinical Data, Inc. Announces Vilazodone Data Pre .. at American Society of Health System Pharmacists
[ Wed, Dec 08th 2010 ] - Market Wire
Cubist Pharmaceuticals to Present at December Investor Conference
[ Wed, Dec 08th 2010 ] - Market Wire
Beobachtungsstudie zeigt kein hheres Auftreten de .. atischen Leukmie mit REVLIMID® bei Patienten mit
[ Wed, Dec 08th 2010 ] - Market Wire
Une ©tude observationnelle ne d©montre aucune i .. s la leuc©mie my©lode aigu avec REVLIMID® chez
[ Wed, Dec 08th 2010 ] - Market Wire
Emergent BioSolutions to Webcast Presentation at JPMorgan Healthcare Conference

Emergent BioSolutions to Webcast Presentation at JPMorgan Healthcare Conference


Published on 2010-12-08 05:22:12 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the 29th Annual JPMorgan Healthcare Conference in San Francisco on Wednesday, January 12, 2011 at 11:30 AM Pacific. During the presentation, a member of the companya™s senior management team will provide a corporate overview, including a discussion of product development programs, corporate activities, preliminary 2010 financial results and financial guidance for 2011.

A webcast of this presentation will be available both live and by replay, accessible from the companya™s website [ www.emergentbiosolutions.com ] under aInvestorsa.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodya™s immune system to prevent or treat disease. Emergenta™s marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information may be found at [ www.emergentbiosolutions.com ].

Contributing Sources